close :

:

Forgotten your password?
 
Professional Information
A-Z Drug Facts > Phenylephrine Tannate/Chlorpheniramine Tannate/Pyrilamine Tannate

Phenylephrine Tannate / Chlorpheniramine Tannate / Pyrilamine Tannate

Pronouncation: (Fen-ill-EFF-rin TAN-ate/klor-fen-AIR-uh-meen TAN-ate/pie-RILL-ah-meen TAN-ate)
Class: Antihistamine, Decongestant, Vasopressor used in shock

Trade Names:
Triotann Pediatric
- Suspension 5 mg phenylephrine, 2 mg chlorpheniramine, 12.5 mg pyrilamine

Trade Names:
Triotann-S Pediatric
- Suspension 5 mg phenylephrine, 2 mg chlorpheniramine, 12.5 mg pyrilamine

Pharmacology

Feedback for Phenylephrine Tannate/Chlorpheniramine Tannate/Pyrilamine Tannate

As a treatment for... Avg User Ratings [?]
Hay Fever Be the first to rate it
Cold Symptoms Be the first to rate it
Compare with other drugs.
Share your Experience Ask a Question
Phenylephrine

Stimulates postsynaptic alpha-receptors, resulting in vasoconstriction which reduces nasal congestion.

Chlorpheniramine and pyrilamine

Competitively antagonizes histamine at H 1 receptor sites.

Indications and Usage

Symptomatic relief of coryza and nasal congestion associated with common cold, sinusitis, allergic rhinitis, and other upper respiratory tract conditions.

Contraindications

Newborns; nursing mothers; sensitivity to any component of product.

Dosage and Administration

Children older than 6 yr of age

PO 5 to 10 mL (1 to 2 tsp) every 12 h.

Children 2 to 6 yr of age

PO 2.5 to 5 mL (½ to 1 tsp) every 12 h.

Children younger than 2 yr of age

PO Titrate dose individually.

General Advice

  • Shake well before measuring dose.
  • Give with food or milk if GI upset occurs.
  • Use dosing spoon or syringe for pediatric doses.

Storage/Stability

Store suspension at controlled room temperature (59° to 77°F). Keep tightly capped and protect from freezing.

Drug Interactions

MAOIs (eg, isocarboxazid [certain drugs for depression, psychiatric or emotional condition, Parkinson disease])

Do not use in patients receiving MAOI therapy or within 14 days of stopping such treatment. May prolong and intensify the effects of chlorpheniramine, pyrilamine, and phenylephrine.

Laboratory Test Interactions

May interfere with diagnostic test results for skin tests using allergen extracts.

Adverse Reactions

CNS

Drowsiness; sedation.

GI

GI effects.

Miscellaneous

Dryness of mucous membranes.

Precautions

Pregnancy

Category C .

Lactation

Do not administer.

Elderly

Chlorpheniramine and pyrilamine are more likely to cause dizziness, sedation, and hypotension in the elderly.

Special Risk Patients

Use with caution in patients with hypertension, heart disease, hyperthyroidism, narrow angle glaucoma, diabetes mellitus, and prostatic hypertrophy.

Excitation

Chlorpheniramine and pyrilamine may cause excitation in children; however, combination with phenylephrine may cause mild stimulation or mild sedation.

Overdosage

Symptoms

CNS depression, CNS stimulation, convulsions, death.

Patient Information

  • Remind patient to shake well before measuring dose.
  • Advise patient to take prescribed dose every 12 h as needed.
  • Advise caregiver to use dosing spoon or syringe when giving suspension to children.
  • Advise patient to take with food or milk if GI upset occurs.
  • Advise patient to take last dose late in the afternoon or early evening to reduce chance of drug causing sleeplessness.
  • Advise patient that if a dose is missed to take as soon as remembered unless it is nearing time for the next dose. Caution patient to not double the dose to catch up.
  • Advise patient that if allergy symptoms are not controlled, not to increase the dose of medication but to inform health care provider.
  • Caution patient that drug may cause drowsiness and to use caution while driving or performing other tasks requiring mental alertness until tolerance is determined.
  • Advise patient to avoid alcohol and other CNS depressants due to risk of excessive sedation.
  • Caution patient not to take any OTC antihistamines or decongestants while taking this medication unless advised by health care provider.
  • If patient is to have allergy skin testing, advise not to take the medication for at least 6 days before the skin testing.
  • Instruct patient to stop taking drug and immediately report any of the following symptoms to health care provider: nervousness, dizziness, sleeplessness.



Compare Phenylephrine Tannate/Chlorpheniramine Tannate/Pyrilamine Tannate with other medications for the treatment of:

Hay Fever, Cold Symptoms

User Reviews:

0 comment(s) about Phenylephrine Tannate/Chlorpheniramine Tannate/Pyrilamine Tannate